Evidence supporting the use of: DHA (docosahexaenoic acid)
For the health condition: Strokes

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

DHA (docosahexaenoic acid) is an omega-3 fatty acid found primarily in fish oils and is essential for normal brain function and structure. Its use in the context of stroke is primarily justified by scientific research, though the evidence is still emerging and not definitive. Experimental studies, particularly in animal models, have shown that DHA can reduce the size of brain infarcts, limit neuronal cell death, and promote neuroplasticity following ischemic stroke. These neuroprotective effects are thought to result from DHA’s anti-inflammatory properties, its role in maintaining neuronal membrane integrity, and its ability to modulate signaling pathways involved in cell survival and apoptosis. Clinical data in humans, however, are limited and mixed. Some observational studies have found that higher dietary intake or blood levels of DHA are associated with a reduced risk of ischemic stroke. A few small-scale clinical trials have investigated omega-3 supplementation (including DHA) post-stroke, with some suggesting modest benefits in neurological outcomes, but these studies often combine DHA with EPA (another omega-3 fatty acid), making it difficult to isolate DHA’s specific effects. Current stroke treatment guidelines do not recommend DHA as a standard therapy due to insufficient evidence from large, randomized controlled trials. In summary, while there is promising preclinical and some epidemiological evidence supporting DHA’s potential role in stroke prevention and recovery, robust clinical validation is lacking. Thus, the overall evidence rating is moderate but far from conclusive.

More about DHA (docosahexaenoic acid)
More about Strokes